The role of cytokines in the immune response to tuberculosis

Research in Immunology

Volumn 147, Issue 8-9, 1996, Pages 565-572

  Kaplan, G ^a   Freedman, V H ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; THALIDOMIDE; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

CELLULAR IMMUNITY; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; IMMUNE RESPONSE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TUBERCULOSIS;

EID: 0030425029     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(97)85223-6     Document Type: Conference Paper

References (62)

1. Akuffo, H., Kaplan, G., Kiessling, R., Teklemariam, S., Dietz, M., McElrath, J. & Cohn, Z.A. (1990), Administration of recombinant interleukin-2 reduces the local parasite load of patients with disseminated cutaneous leishmaniasis. J. Infect. Dis., 161, 775-780.
2. Balaji, K.N., Schwander, S.K., Rich, E.A. & Boom, W.H. (1995), Alveolar macrophages as accessory cells for human γδ T cells activated by Mycobacterium tuberculosis. J. Immunol., 154, 5959-5968.
3. Barnes, P.F., Fong, S.J., Brennan, P.F., Twomey, P.E., Mazumder, A. & Modlin, R.L. (1990), Local production of tumor necrosis factor and IFN-gamma in tuberculosis pleuritis. J. Immunol., 145, 149-154.
4. Barnes, P.F., Lu Shuzhuang, Abrams, J.S., Wang, E., Yamamura, M. & Modlin, R.L. (1993), Cytokine production at the site of disease in human tuberculosis. Infect. Immun., 61, 3482-3489.
5. Barnes, P.F., Modlin, R.L. & Ellner, J.J. (1994), T-Cell responses and cytokines in "Tuberculosis: Pathogenesis, Protection, and Control". (B.R. Bloom) (pp. 417-435). ASM Press, Washington DC.
6. Bermudez, L.E., Stevens, P., Kolonoski, P., Wu, M. & Young, L.S. (1989), Treatment of experimental disseminated mycobacterium avium complex infection in mice with recombinant IL-2 and tumor necrosis factor. J. Immunol., 143, 2996-3000.
7. Bermudez, L.E. & Kaplan, G. (1995), Recombinant cytokines for controlling mycobacterial infections. Trends Microbiol., 3, 22-26.
8. Beutler, B. & Cerami, A. (1988), The common mediator of shock, cachexia and tumor necrosis. Adv. Immunol., 42, 213-231.
9. Bloom, B.R. & Murray, C.J.L. (1992), TB: Commentary on a reemergent killer. Science, 257, 1055-1064.
10. Bloom, B.R. & Fine, P.E.M. (1994), The BCG experience: Implications for future vaccines against tuberculosis, in "Tuberculosis: Pathogenesis, Protection, and Control". (B.R. Bloom) (pp. 531-557). ASM Press, Washington DC.
11. Boom, W.H., Chervenak, K.A., Mincek, M.A. & Ellner, J.J. (1992), Role of the mononuclear phagocyte as an antigen-presenting cell for human γδ T cells activated by live M. tuberculosis. Infect. Immun., 60, 3480-3488.
12. Braunstein, S., Kaplan, G., Gottlieb, A.B., Schwartz, M., Walsh, G., Abalos, R.M., Fajardo, T.T., Guido, L.S. & Krueger, J.G. (1994), GM-CSF activates regenerative epidermal growth and stimulates keratinocyte proliferation in human skin in vivo. J. Invest. Derm., 103, 601-604.
13. Brown, D.H., Miles, B.A. & Zwilling, B.S. (1995), Growth of Mycobacterium tuberculosis in BCG-resistant and -susceptible mice: Establishment of latency and reactivation. Infect. Immun., 63, 2243-2247.
14. Cohn, Z.A. (1992), The enhancement of cell-mediated immunity with recombinant lymphokines: Studies in leprosy and AIDS, in "Immunology in the 21st Century". (F.W. Alt) (pp. 109-126). Sigma Chemical Co., St. Louis, MO.
15. Converse, P., Ottenhoff, T.H.M., Teklemarian, S.W., Hancock, G., Dietz, M., Becx-Bleumink, M., Wondimu, A., Kiessling, R., Cohn, Z.A. & Kaplan, G. (1991), Intradermal recombinant interleukin 2 enhances peripheral blood T-cell responses to mitogen and antigens in patients with lepromatous leprosy. Scan. J. Immunol., 32, 83-91.
16. Cooper, A.M., Dalton, D.K., Stewart, T.A., Griffin, J.P., Russel, D.G. & Orme, I.M. (1993), Disseminated tuberculosis in interferon γ gene-disrupted mice. J. Exp. Med., 178, 2243-2247.
17. Dannenberg, A.M., Jr. (1982), Pathogenesis of pulmonary tuberculosis. Am. Rev. Resp. Dis., 125, 25-29.
18. Denis, M. (1991), Involvement of cytokines in determining resistance and acquired immunity in murine tuberculosis. J. Leukocyte Biol., 50, 495-501.
19. Douvas, G.S., Lookes, D.L., Vatter, A.E. & Crowie, A.J. (1985), Gamma interferon activates human macrophages to become tumoricical and leishmanicidal but enhances replication of macrophage-associated mycobacteria. Infect. Immun., 50, 1-8.
20. Dunn, P.L. & North, R.J. (1995), Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice. Infect. Immun., 63, 3428-3437.
21. Flesch, I. & Kaufmann, S.J.E. (1987), Mycobacterial growth inhibition by interferon-γ activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis. J. Immunol., 138, 4408-4413.
22. Flynn, J.L., Chan, J., Triebold, K.J., Dalton, D.K., Steward, T.A. & Bloom, B.R. (1993), An essential role for IFN-γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med., 178, 2249-2254.
23. George, R.B., Penn, R.L. & Kinasewitz, G.T. (1985), Mycobacterial, fungal, actinomycotic, and nocardial infections of the pleura. Clin. Chest Med., 6, 63-75.
24. Hancock, G.E., Kaplan, G. & Cohn, Z.A. (1988), Keratinocyte growth regulation by the products of immune cells. J. Exp. Med., 168, 1395-1402.
25. Hancock, G.E., Cohn, Z.A. & Kaplan, G. (1989), The generation of antigen-specific, major histocompatibility complex-restricted cytotoxic T lymphocytes of the CD4+ phenotype. Enhancement by the cutaneous administration of interleukin 2. J. Exp. Med., 169, 909-919.
26. Hancock, G.E., Molloy, A., Kale, A.B., Kiessling, R., Becx-Bleumink, M., Cohn, Z.A. & Kaplan, G. (1991) In vivo administration of low-dose human interleukin-2 induces lymphokine-activated killer cells for enhanced cytolysis in vitro. Cell. Immunol., 132, 277-284.
27. Havell, E.A. (1989), Evidence that tumor necrosis factor has an important role in antibacterial resistance. J. Immunol., 143, 2894-2901.
28. Jeevan, A. & Asherson, G.L. (1988), Recombinant interleukin-2 limits the replication of Mycobacterium lepraemurium and Mycobacterium bovis BCG in mice. Lymphokine Res., 7, 2.
29. Johnson, B.J., Ress, S.R., Willcox, P., Pati, B.P., Lorgat, F., Stead, P., Lukey, P., Laochumroonvorapong, P., Corral, L. & Kaplan, G. (1995), Clinical and immune responses of tuberculosis patients treated with low dose IL-2 and multi-drug therapy. Cyto. Molec. Ther., 1, 185-196.
30. Kaplan, G., Witmer, M.D., Nath, I., Steinman, R.M., Laal, S., Prasad, H.K., Sarno, E.N., Elvers, U. & Cohn, Z.A. (1986), The influence of delayed immune reactions on human epidermal keratinocytes. Proc. Natl. Acad. Sci. USA, 83, 3469-3473.
31. Kaplan, G., Nusrat, A., Witmer, M.D., Nath, I. & Cohn, Z.A. (1987), The distribution and turnover of Langerhans cells during delayed immune responses in human skin. J. Exp. Med., 165, 763-776.
32. Kaplan, G., Kiessling, R., Teklemariam, S., Hancock, G., Sheftel, C., Job, C.K., Converse, P., Ottenhoff, T.H.M., Becx-Bleumink, M., Dietz, M. & Cohn, Z.A. (1989), The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2. J. Exp. Med., 169, 893-907.
33. Kaplan, G., Britton, W.J., Hancock, G.E., Theuvenet, W.J., Smith, K.A., Job, C.K., Roche, P.W., Molloy, A., Burkhardt, R., Barker, J., Pradhan, H.M. & Cohn, Z.A. (1991), The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy. J. Exp. Med., 173, 993-1006.
34. Kaplan, G., Walsh, G., Guido, L.S., Meyn, P., Burkhardt, R.A., Abalos, R.M., Barker, J., Frindt, P.A., Fajardo, T.T., Cellona, R. & Cohn, Z.A. (1992a), Novel responses of human skin to intradermal rGM-CSF: Langerhans cell recruitment, keratinocyte growth and enhanced wound healing. J. Exp. Med., 175, 1717-1728.
35. Kaplan, G., Cohn, Z.A. & Smith, K.A. (1992b), Rational immunotherapy with interleukin 2. Biotech., 10, 157-162.
36. Kaplan, G. & Moreira, A. (1994), TNF-α regulation of HIV-1: biology and therapy. Res. Immunol., 145, 685-690.
37. Kindler, V., Sappino, A.P., Grau, G.E., Piguet, P.F. & Vassali, P. (1989), The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell., 56, 731-740.
38. Koch, F., Heufler, C., Kampgen, E., Schneeweiss, D., Bock, G. & Schuler, G. (1990), Tumor necrosis factor alpha maintains the viability of murine epidermal Langerhans cells in culture, but in contrast to granulocyte/macrophage colony-stimulating factor, without inducing their functional maturation. J. Exp. Med., 171, 159-171.
39. Kong, D. & Kunimoto, D.Y. (1995), Secretion of human interleukin 2 by recombinant Mycobacterium bovis BCG. Infect. Immun., 63, 799-803.
40. Maeda, J. Ueki, N., Ohkawa, T., Iwahashi, N., Nakano, T., Hada, T. & Higashino, K. (1993), Local production and localization of transforming growth factor-beta in tuberculous pleurisy. Clin. Exp. Immunol., 92, 32-38.
41. McCabe, R.E., Luft, B.J. & Remington, J.S. (1984), Effect of murine interferon gamma on murine toxoplasmosis. J. Infect. Dis., 150, 961-962.
42. McElrath, M.J., Kaplan, G., Burkhardt, R.A. & Cohn, Z.A. (1990), Cutaneous reponse to recombinant interleukin 2 in human immunodeficiency virus 1-seropositive individuals. Proc. Natl. Acad. Sci. USA, 87, 5783-5787.
43. Moreno, C., Taverne, J., Mehlert, A., Bate, C.A., Brealey, R.J., Meager, A., Rook, G.A. & Playfair, J.H. (1989), Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages. Clin. Exp. Immunol., 76, 240-245.
44. Murray, H., Rubin, B.Y. & Rothermel, C.F. (1983), Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. J. Clin. Invest., 72, 1506-1510.
45. Ogawa, T., Uchida, H., Kusumoto, Y., Mori, Y., Yamamura, Y. & Hamada, S. (1991), Increase in tumor necrosis factor alpha- and interleukin-6-secreting cells in peripheral blood mononuclear cells from subjects infected with Mycobacterium tuberculosis. Infect. Immun., 59, 3021-3025.
46. Orme, I.M., Anderson, P. & Boom, W.H. (1993), T cell response to M. tuberculosis. J. Infect. Dis., 167, 1481-1497.
47. Orme, I.M. & Collins, F.M. (1994), Mouse model of tuberculosis, in "Tuberculosis: Pathogenesis, Protection and Control". (B.R. Bloom) (pp. 113-134). ASM Press, Washington, DC.
48. Sampaio, E.P., Moreira, A.L., Sarno, E.N., Malta, A.M. & Kaplan, G. (1992), Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients. J. Exp. Med. 175, 1729-1737.
49. Sampaio, E.P., Kaplan, G., Miranda, A., Nery, J.A.C., Miguel, C., Viana, S.M. & Sarno, E.N. (1993), The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum. J. Infect. Dis., 168, 408-414.
50. Sampaio, E.P., Malta, A.M., Sarno, E.N. & Kaplan, G. (1996), Effect of rhuIFN-γ treatment in multibacillary leprosy patients. Int. J. Lep., 64, 268-273.
51. Schauf, V., Rom, W.N., Smith, K.A., Sampaio, E.P., Meyn, P.A., Tramontana, J.M., Cohn, Z.A. & Kaplan, G. (1993), Cytokine gene activation and modified responsiveness to IL-2 in the blood of tuberculosis patients. J. Infect. Dis., 168, 1056-1059.
52. Streilein, J.W. (1995), Local factors govern antigen processing and presentation. (Abs. 62, September 13-16), Society for Leukocyte Biology 31st National Meeting, Marco Island, FL.
53. Takashima, T., Ueta, C., Tsuyuguchi, I. & Kishimoto, S. (1990), Production of tumor necrosis factor alpha by monocytes from patients with pulmonary tuberculosis. Infect. Immun., 58, 3286-3292.
54. Teppler, H., Kaplan, G., Smith, K.A., Cameron, P., Montana, A., Meyn, P. & Cohn, Z.A. (1993), Efficacy of low doses of the polyethylene glycol derivative of IL-2 in modulating the immune response of patients with HIV-1 infection. J. Infect. Dis., 167, 291-298.
55. Toossi, Z., Kleinhenz, M.E. & Ellner, J.J. (1986), Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis. J. Exp. Med., 163, 1162-1172.
56. Tracey, K.J. & Cerami, A. (1992), Tumor necrosis factor in the malnutrition (cachexia) of infection and cancer. Am. J. Trop. Med. Hyg., 47, 2-7.
57. Tramontana, J.M., Utaipat, U., Molloy, A., Akarasewi, P., Burroughs, M., Makonkawkeyoon, S., Johnson, B., Klausner, J.D., Rom, W. & Kaplan, G. (1995), Thalidomide treatment reduces tumor necrosis factor-α production and enhances weight gain in patients with pulmonary tuberculosis. Mol. Med., 1, 384-397.
58. Valone, S.E., Rich, E.A., Wallis, R.S. & Ellner, J.J. (1988), Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens. Infect. Immun., 56, 3313-3315.
59. Wallis, R.S., Amir-Tahmasseb, M. & Ellner, J.J. (1990), Induction of interleukin 1 and tumor necrosis factor by mycobacterial proteins: the monocyte western blot. Proc. Nat. Acad. Sci. USA, 87, 3348-3352.
60. Wallis, R.S. & Ellner, J.J. (1994), Cytokines and tuberculosis. J. Leuk. Biol., 55, 676-681.
61. Witmer-Pack, M.D., Olivier, W., Valinsky, J., Schuler, G. & Steinman, R.M. (1987), Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J. Exp. Med., 166, 1484-1498.
62. Zhang, Y., Doerfler, M., Lee, T.C., Guillemin, B. & Rom, W.N. (1993), Mechanisms of stimulation of interleukin-1 and tumor necrosis factor-α by Mycobacterium tuberculosis components. J. Clin. Invest., 91, 2076-2083.